<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.iovs.org">
<title>Investigative Ophthalmology &amp; Visual Science current issue</title>
<link>http://www.iovs.org</link>
<description>Investigative Ophthalmology &amp; Visual Science RSS feed -- current issue</description>
<prism:coverDisplayDate>May  1 2008 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Investigative Ophthalmology &amp; Visual Science</prism:publicationName>
<prism:issn>0146-0404</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1745?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1753?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1758?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1762?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1763?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1771?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1777?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1784?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1791?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1797?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1809?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1814?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1827?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1836?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1843?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1850?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1857?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1864?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1872?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1879?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1886?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1898?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1907?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1916?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1924?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1932?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1940?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1946?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1957?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1971?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1979?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1983?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1991?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/1998?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2004?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2009?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2016?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2025?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2030?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2039?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2046?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2053?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2061?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2071?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2077?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2082?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2094?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2103?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2120?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2127?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2134?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2143?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2148?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2156?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2163?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2172?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2178?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2193?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2201?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2208?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/content/full/49/5/2216?rss=1" />
  <rdf:li rdf:resource="http://www.iovs.org/cgi/reprint/49/5/2223?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.iovs.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.iovs.org/icons/banner/title.gif">
<title>Investigative Ophthalmology &amp; Visual Science</title>
<url>http://www.iovs.org/icons/banner/title.gif</url>
<link>http://www.iovs.org</link>
</image>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1745?rss=1">
<title><![CDATA[[Clinical Trials] Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in Eyes with Diabetic Macular Edema]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1745?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To explore the correlation between optical coherence tomography (OCT) and stereoscopic fundus photographs (FP) for the assessment of retinal thickening (RT) in diabetic macular edema (DME) within a clinical trial.</p>
<p><scp>methods.</scp> OCT, FP, and best corrected visual acuity (VA) measurements were obtained in both eyes of 263 participants in a trial comparing two photocoagulation techniques for DME. Correlation coefficients (<I>r</I>) were calculated comparing RT measured by OCT, RT estimated from FP, and VA. Principal variables were central subfield retinal thickness (CSRT) obtained from the OCT fast macular map and DME severity assessed by a reading center using a seven-step photographic scale combining the area of thickened retina within 1 disc diameter of the foveal center and thickening at the center.</p>
<p><scp>results.</scp> Medians (quartiles) for retinal thickness within the center subfield by OCT at baseline increased from 236 (214, 264) &micro;m in the lowest level of the photographic scale to 517 (455, 598) &micro;m in the highest level (<I>r</I> = 0.67). However, CSRT interquartile ranges were broad and overlapping between FP scale levels, and there were many outliers. Correlations between either modality and VA were weaker (<I>r</I> = 0.57 for CSRT, and <I>r</I> = 0.47 for the FP scale). OCT appeared to be more reproducible and more sensitive to change in RT between baseline and 1 year than was FP.</p>
<p><scp>conclusions.</scp> There was a moderate correlation between OCT and FP assessments of RT in patients with DME and slightly less correlation of either measure with VA. OCT and FP provide complementary information but neither is a reliable surrogate for VA. (ClinicalTrials.gov number, NCT00071773.)</p>
]]></description>
<dc:creator><![CDATA[Davis, M. D., Bressler, S. B., Aiello, L. P., Bressler, N. M., Browning, D. J., Flaxel, C. J., Fong, D. S., Foster, W. J., Glassman, A. R., Hartnett, M. E. R., Kollman, C., Li, H. K., Qin, H., Scott, I. U., the Diabetic Retinopathy Clinical Research Network Study Group]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1257</dc:identifier>
<dc:title><![CDATA[[Clinical Trials] Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in Eyes with Diabetic Macular Edema]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1752</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1745</prism:startingPage>
<prism:section>Clinical Trials</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1753?rss=1">
<title><![CDATA[[Anatomy and Pathology] Overlapping of Retinal Nerve Fibers in the Horizontal Plane]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1753?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To describe a previously unreported overlapping trajectory of retinal nerve fibers over other retinal nerve fibers in the horizontal plane, and to report on the incidence of this anatomic variation.</p>
<p><scp>methods.</scp> This study included 1410 eyes of 1018 subjects with one or more localized retinal nerve fiber layer (RNFL) defects detected by using red-free fundus photography. All red-free fundus photographs were reviewed, and eyes with overlapping retinal nerve fibers in the horizontal plane were selected. Overlapping nerve fibers were defined as fibers with a trajectory nonparallel to the adjacent fibers, according to the red-free fundus photographs.</p>
<p><scp>results.</scp> Overlapping of retinal nerve fibers was detected in 33 eyes of 30 subjects. The estimated incidence of overlapping retinal nerve fibers was 2.3% (95% confidence interval [CI], 1.6%&ndash;3.1%) per eye and 2.9% (95% CI, 1.9%&ndash;4.0%) per subject. For all 33 eyes, a localized arcuate RNFL defect was observed in the inferotemporal quadrant and was partially overlapped by relatively straight nerve fibers. Optical coherence tomography confirmed the overlying retinal nerve fibers and showed a decrease in the RNFL thickness at the corresponding location of the adjacent RNFL defect.</p>
<p><scp>conclusions.</scp> Overlapping retinal nerve fibers were identified in the horizontal plane in 33 eyes. In those eyes, the localized RNFL defect was partially obscured by the overlying nerve fibers, leading to an unusual appearance of the RNFL defect. Awareness of this anatomic variation may help clinicians to avoid overlooking RNFL defects that are obscured by overlapping bundles.</p>
]]></description>
<dc:creator><![CDATA[Jeoung, J. W., Kim, T.-W., Kang, K. B., Lee, J. J., Park, K. H., Kim, D. M.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1408</dc:identifier>
<dc:title><![CDATA[[Anatomy and Pathology] Overlapping of Retinal Nerve Fibers in the Horizontal Plane]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1757</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1753</prism:startingPage>
<prism:section>Anatomy and Pathology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1758?rss=1">
<title><![CDATA[[Anatomy and Pathology] A New and Validated CT-Based Method for the Calculation of Orbital Soft Tissue Volumes]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1758?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> There is no consensus as how to calculate orbital soft tissue volume based on CT or MRI scans. The authors sought to validate their technique and to assess the intraobserver and interobserver variability of their calculations of bony orbital volume (OV), orbital fat volume (FV), and extraocular muscle volume (MV) on CT scans of humans.</p>
<p><scp>methods.</scp> The authors calculated these volumes with the use of a manual segmentation technique on CT scans with commercially available software. Two observers (one of them masked) calculated the orbital soft tissue volumes in a CT scan of a phantom constructed of dry skull, butter, and chicken muscle. These calculations were compared with previously taken standard volume measurements of these materials. Repetitive calculations on one CT scan by the same observer were compared. Soft tissue volumes taken from 10 orbital CT scans were calculated by two observers and compared. From the data acquired, intraobserver and interobserver variability was calculated.</p>
<p><scp>results.</scp> Outcomes of these calculations using this software approximated the volumes of the phantom measured with standardized techniques. Accuracy of the phantom calculations between the two observers varied from +0.7% to &ndash;0.7% for FV and between &ndash;1.5% and &ndash;2.2% for MV. Mean differences between the repeated calculations were smaller than 5%. The intraclass correlation coefficient varied from 0.961 to 0.999.</p>
<p><scp>conclusions.</scp> Calculating orbital soft tissue volume using a manual segmentation technique for CT scans is a reliable and accurate tool.</p>
]]></description>
<dc:creator><![CDATA[Regensburg, N. I., Kok, P. H. B., Zonneveld, F. W., Baldeschi, L., Saeed, P., Wiersinga, W. M., Mourits, M. P.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1030</dc:identifier>
<dc:title><![CDATA[[Anatomy and Pathology] A New and Validated CT-Based Method for the Calculation of Orbital Soft Tissue Volumes]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1762</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1758</prism:startingPage>
<prism:section>Anatomy and Pathology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1762?rss=1">
<title><![CDATA[[Erratum] ERRATUM]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1762?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:title><![CDATA[[Erratum] ERRATUM]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1762</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1762</prism:startingPage>
<prism:section>Erratum</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1763?rss=1">
<title><![CDATA[[Biochemistry and Molecular Biology] Functional and Structural Implications of the Complement Factor H Y402H Polymorphism Associated with Age-Related Macular Degeneration]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1763?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> A Tyr-to-His (Y402H) sequence variant in the factor H (<I>FH</I>) and factor H-like protein (<I>FHL-1</I>) gene is strongly associated with an increased susceptibility for age-related macular degeneration (AMD). The purpose of this study was to understand how the Y402H variant in FH/FHL-1 contributes to the pathogenesis of AMD and, in particular, whether interactions mediated by FH/FHL-1, including binding to C-reactive protein (CRP), group A streptococcal M protein (GAS M6), heparin, and retinal pigment epithelial cells (RPE), are affected.</p>
<p><scp>methods.</scp> FH was purified from sera of patients homozygous for FH(Y402) or (H402), and recombinant FH fragments representing FHL-1 were generated. Proteins were analyzed for binding to CRP, GAS M6, heparin, and RPE cells.</p>
<p><scp>results.</scp> Binding of the FH and FH1 to seven polymorphic variants to CRP and M protein was reduced. The variant did not influence the interaction of FH with heparin but did reduce binding of FHL-1. Binding of the FH and FHL-1 polymorphic variant to RPE cells was not affected.</p>
<p><scp>conclusions.</scp> The FH Y402H polymorphism associated with AMD causes a reduction in binding of FH and FHL-1 to CRP and M protein. Both variants show comparable binding to RPE cells, indicating that AMD is unlikely to manifest as a result of impaired host cell-surface recognition. The decreased interaction between FH and CRP, which is essential for the anti-inflammatory function of CRP, provides a possible pathophysiological explanation for the association of the Y402H variant with AMD.</p>
]]></description>
<dc:creator><![CDATA[Ormsby, R. J., Ranganathan, S., Tong, J. C., Griggs, K. M., Dimasi, D. P., Hewitt, A. W., Burdon, K. P., Craig, J. E., Hoh, J., Gordon, D. L.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1297</dc:identifier>
<dc:title><![CDATA[[Biochemistry and Molecular Biology] Functional and Structural Implications of the Complement Factor H Y402H Polymorphism Associated with Age-Related Macular Degeneration]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1770</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1763</prism:startingPage>
<prism:section>Biochemistry and Molecular Biology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1771?rss=1">
<title><![CDATA[[Biochemistry and Molecular Biology] Variants in the 10q26 Gene Cluster (LOC387715 and HTRA1) Exhibit Enhanced Risk of Age-Related Macular Degeneration along with CFH in Indian Patients]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1771?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Single nucleotide polymorphisms (SNPs) in the <I>LOC387715</I> (rs10490924), <I>HTRA1</I> (rs11200638), and <I>CFH</I> (rs1061170) genes have been implicated in age-related macular degeneration (AMD). The present study was undertaken to determine the involvement of the <I>LOC387715</I> and <I>HTRA1</I> in an AMD cohort from India.</p>
<p><scp>methods.</scp> The coding region of <I>LOC387715</I> (exon 1) and the promoter of <I>HTRA1</I> were screened by resequencing in AMD cases and normal controls. Odds ratios were calculated to assess the risk of individual genotypes. Linkage disequilibrium (LD) and haplotype frequencies were estimated with Haploview software. Population attributable risk (PAR %) for the associated SNPs and their combined effects were calculated.</p>
<p><scp>results.</scp> Resequencing revealed seven different SNPs in these genes, of which significant associations were noted with the risk alleles of rs10490924 (T allele; <I>P</I> = 5.34 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;12</sup>) in <I>LOC387715</I>, and rs11200638 (A allele; <I>P</I> = 4.32 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;12</sup>) and rs2672598 (C allele; <I>P</I> = 3.39 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;11</sup>) in <I>HTRA1</I> among the cases. Correspondingly, the homozygous risk genotypes TT, AA, and CC in these SNPs exhibited higher disease odds and PAR %. rs10490924 and rs11200638 were in tight LD (D', 0.90; 95% CI, 0.84&ndash;0.93). G-C-T-A-C was the risk haplotype (<I>P</I> = 8.04 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;15</sup>), whereas the G-C-G-G-T haplotype was protective (<I>P</I> = 2.01 <FONT FACE="arial,helvetica">x</FONT> 10<sup>&ndash;4</sup>). The combined effect of the <I>CFH</I> (CC) and <I>LOC387715</I> (TT) risk genotypes exhibited a PAR of 93.7% (OR, 73.89; 95% CI, 8.69&ndash;628.13).</p>
<p><scp>conclusions.</scp> The present data provided an independent validation of the association of <I>LOC387715</I> and <I>HTRA1</I> SNPs, along with their risk estimates among Indian patients with AMD. These associations underscore their significant involvement in AMD susceptibility, which may be useful for predictive testing.</p>
]]></description>
<dc:creator><![CDATA[Kaur, I., Katta, S., Hussain, A., Hussain, N., Mathai, A., Narayanan, R., Hussain, A., Reddy, R. K., Majji, A. B., Das, T., Chakrabarti, S.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0560</dc:identifier>
<dc:title><![CDATA[[Biochemistry and Molecular Biology] Variants in the 10q26 Gene Cluster (LOC387715 and HTRA1) Exhibit Enhanced Risk of Age-Related Macular Degeneration along with CFH in Indian Patients]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1776</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1771</prism:startingPage>
<prism:section>Biochemistry and Molecular Biology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1777?rss=1">
<title><![CDATA[[Biochemistry and Molecular Biology] Light-Induced Decomposition of Indocyanine Green]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1777?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To investigate the light-induced decomposition of indocyanine green (ICG) and to test the cytotoxicity of light-induced ICG decomposition products.</p>
<p><scp>methods.</scp> ICG in solution was irradiated with laser light, solar light, or surgical endolight. The light-induced decomposition of ICG was analyzed by high-performance liquid chromatography (HPLC) and mass spectrometry. Porcine retinal pigment epithelial (RPE) cells were incubated with the light-induced decomposition products of ICG, and cell viability was measured by trypan blue exclusion assay.</p>
<p><scp>results.</scp> Independent of the light source used, singlet oxygen (photodynamic type 2 reaction) is generated by ICG leading to dioxetanes by [2+2]-cycloaddition of singlet oxygen. These dioxetanes thermally decompose into several carbonyl compounds. The decomposition products were identified by mass spectrometry. The decomposition of ICG was inhibited by adding sodium azide, a quencher of singlet oxygen. Incubation with ICG decomposition products significantly reduced the viability of RPE cells in contrast to control cells.</p>
<p><scp>conclusions.</scp> ICG is decomposed by light within a self-sensitized photo oxidation. The decomposition products reduce the viability of RPE cells in vitro. The toxic effects of decomposed ICG should be further investigated under in vivo conditions.</p>
]]></description>
<dc:creator><![CDATA[Engel, E., Schraml, R., Maisch, T., Kobuch, K., Konig, B., Szeimies, R.-M., Hillenkamp, J., Baumler, W., Vasold, R.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0911</dc:identifier>
<dc:title><![CDATA[[Biochemistry and Molecular Biology] Light-Induced Decomposition of Indocyanine Green]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1783</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1777</prism:startingPage>
<prism:section>Biochemistry and Molecular Biology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1784?rss=1">
<title><![CDATA[[Clinical and Epidemiologic Research] Retinal Vascular Caliber, Blood Pressure, and Cardiovascular Risk Factors in an Asian Population: The Singapore Malay Eye Study]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1784?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To describe the relationship of retinal vascular caliber with cardiovascular risk factors in an Asian population.</p>
<p><scp>methods.</scp> The Singapore Malay Eye Study is a population-based, cross-sectional survey that included 3280 (78.7% response) persons aged 40 to 80 years. Retinal vascular caliber was measured from digital retinal photographs using a validated standardized protocol. Data on major cardiovascular risk factors were collected from all participants.</p>
<p><scp>results.</scp> Of the 3019 participants with retinal vascular caliber data available, the mean retinal arteriolar caliber (CRAE) was 139.5 &plusmn; 15.7 &micro;m (SD), and mean venular caliber (CRVE) was 219.3 &plusmn; 22.2 &micro;m (SD). Smaller retinal arteriolar caliber was associated with higher current mean blood pressure and male sex (<I>P</I> &lt; 0.001 for both). Larger retinal venular caliber was associated with younger age, current cigarette smoking, greater body mass index, higher glycosylated hemoglobin level, and lower HDL cholesterol (<I>P</I> = 0.012 for glycosylated hemoglobin level and <I>P</I> &lt; 0.001 for other risk factors). The association of retinal arteriolar narrowing and blood pressure was stronger in younger people than in older people and in men than in women (<I>P</I> for interaction &lt; 0.001 for both).</p>
<p><scp>conclusions.</scp> In this Asian population, smaller retinal arteriolar caliber was associated with hypertension and larger retinal venular caliber with cigarette smoking, dyslipidemia, hyperglycemia, and higher body mass index. The pattern of these associations is similar to that in white populations.</p>
]]></description>
<dc:creator><![CDATA[Sun, C., Liew, G., Wang, J. J., Mitchell, P., Saw, S. M., Aung, T., Tai, E. S., Wong, T. Y.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1450</dc:identifier>
<dc:title><![CDATA[[Clinical and Epidemiologic Research] Retinal Vascular Caliber, Blood Pressure, and Cardiovascular Risk Factors in an Asian Population: The Singapore Malay Eye Study]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1790</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1784</prism:startingPage>
<prism:section>Clinical and Epidemiologic Research</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1791?rss=1">
<title><![CDATA[[Clinical and Epidemiologic Research] Risk of Glaucoma after Pediatric Cataract Surgery]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1791?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To determine the risk of glaucoma after surgery for pediatric cataract and to evaluate risk factors for glaucoma.</p>
<p><scp>methods.</scp> A population-based cohort of all children in Denmark aged 0 to 17 years during the period 1977 to 2001, who underwent surgery for pediatric cataract, was established by retrospective chart review. Glaucoma cases were defined as those in which glaucoma surgery (trabeculectomy and/or diode laser transscleral cyclophotocoagulation) was performed and/or permanent medical therapy prescribed after cataract surgery.</p>
<p><scp>results.</scp> Of 946 eyes (595 patients) undergoing pediatric cataract surgery, 72 eyes (48 patients) had subsequent development of glaucoma. Early surgery (&lt;9 months of age) was associated with a 7.2-fold increased risk of glaucoma compared with late surgery (&ge;9 months of age). Ten years after cataract surgery, glaucoma developed in 31.9% (95% confidence interval [CI], 24.4&ndash;41.1) of children undergoing surgery before 9 months of age compared with 4.1% (95% CI, 2.4 to 6.8) of children aged &ge;9 months at the time of surgery. Glaucoma cases continued to occur more than 10 years after cataract surgery. After adjustment for age at surgery, no other risk factor appeared important.</p>
<p><scp>conclusions.</scp> The risk of glaucoma after surgery for pediatric cataract is substantial and particularly high for those below 9 months of age at the time of surgery. Because the increased risk persists for many years after surgery, careful continuous monitoring for glaucoma is mandatory.</p>
]]></description>
<dc:creator><![CDATA[Haargaard, B., Ritz, C., Oudin, A., Wohlfahrt, J., Thygesen, J., Olsen, T., Melbye, M.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1156</dc:identifier>
<dc:title><![CDATA[[Clinical and Epidemiologic Research] Risk of Glaucoma after Pediatric Cataract Surgery]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1796</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1791</prism:startingPage>
<prism:section>Clinical and Epidemiologic Research</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1797?rss=1">
<title><![CDATA[[Cornea] Estrogen and Progesterone Control of Gene Expression in the Mouse Meibomian Gland]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1797?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> The purpose of the study was to test the hypothesis that estrogen and progesterone regulate gene expression in the meibomian gland.</p>
<p><scp>methods.</scp> Meibomian glands were obtained from young adult, ovariectomized mice that were administered 17&beta;-estradiol, progesterone, 17&beta;-estradiol plus progesterone, or vehicle for 14 days. Glands were pooled according to treatment, processed for the extraction of RNA, and analyzed for differentially expressed mRNAs by using mouse gene microarrays. Bioarray data were evaluated with sophisticated bioinformatics software and statistical programs. The expression of selected genes was confirmed with gene chips and quantitative real-time PCR techniques.</p>
<p><scp>results.</scp> The findings show that 17&beta;-estradiol, progesterone, or both hormones administered together significantly influenced the expression of numerous genes in the mouse meibomian gland. Notable were the effects of 17&beta;-estradiol on genes related to lipid metabolism, tyrosine kinases, immune factors, extracellular matrix components, steroidogenesis, and prolactin dynamics. Also very significant were the actions of progesterone or 17&beta;-estradiol plus progesterone on ribosome or localization gene ontologies, respectively. The various hormone treatments led to many analogous, opposite, or unique effects on gene expression.</p>
<p><scp>conclusions.</scp> These findings support the study hypothesis that estrogen and progesterone modulate gene expression in the meibomian gland.</p>
]]></description>
<dc:creator><![CDATA[Suzuki, T., Schirra, F., Richards, S. M., Jensen, R. V., Sullivan, D. A.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1458</dc:identifier>
<dc:title><![CDATA[[Cornea] Estrogen and Progesterone Control of Gene Expression in the Mouse Meibomian Gland]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1808</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1797</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1809?rss=1">
<title><![CDATA[[Cornea] Association of Combined IL-13/IL-4R Signaling Pathway Gene Polymorphism with Stevens-Johnson Syndrome Accompanied by Ocular Surface Complications]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1809?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute-onset mucocutaneous diseases induced by infectious agents or inciting drugs. The authors previously reported an association between SJS/TEN and <I>IL-4R</I> gene polymorphism that is essential for IL-4 and IL-13 signaling. To examine <I>IL-4</I> and <I>IL-13</I> gene polymorphisms and the combination of these polymorphisms with <I>IL-4R</I> polymorphism, the authors performed polymorphism analysis.</p>
<p><scp>methods.</scp> In 76 Japanese SJS/TEN patients with ocular surface complications and 160 healthy controls, the authors analyzed polymorphisms of the promoter &ndash;590C/T in the <I>IL-4</I> gene and of the promoter &ndash;1111C/T and Arg110Gln in the <I>IL-13</I> gene and assessed Gln551Arg in the <I>IL-4R</I> gene. Because Arg110Gln affects serum IL-13, plasma IL-13 levels were also examined.</p>
<p><scp>results.</scp> In the SJS/TEN patients, the Arg110Gln SNP of <I>IL-13</I> was significantly associated with the disease, and the frequency of Arg110 alleles was significantly higher than that in the controls. Plasma IL-13 tended to be lower in SJS/TEN patients than in the controls. Analysis of the genotype pattern of <I>IL-4R</I> SNP Gln551Arg and <I>IL-13</I> SNP Arg110Gln showed that the Gln551Gln(A/A)-Arg110Arg(G/G) genotype pattern was also associated with SJS/TEN.</p>
<p><scp>conclusions.</scp> <I>IL-13</I> gene polymorphisms might be associated with SJS/TEN with ocular surface complications. The present findings suggest that SJS/TEN is different from allergic diseases such as atopy and asthma because the ratio of each allele in the <I>IL-13</I> SNP Arg110Gln was the opposite of the ratio in those diseases. They also reveal that combined polymorphisms in the IL-13/IL-4R signaling pathway were associated with SJS/TEN with ocular surface complications.</p>
]]></description>
<dc:creator><![CDATA[Ueta, M., Sotozono, C., Inatomi, T., Kojima, K., Hamuro, J., Kinoshita, S.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1401</dc:identifier>
<dc:title><![CDATA[[Cornea] Association of Combined IL-13/IL-4R Signaling Pathway Gene Polymorphism with Stevens-Johnson Syndrome Accompanied by Ocular Surface Complications]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1813</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1809</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1814?rss=1">
<title><![CDATA[[Cornea] Gene Expression of the Mouse Corneal Crystallin Aldh3a1: Activation by Pax6, Oct1, and p300]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1814?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Aldehyde dehydrogenase 3a1 (Aldh3a1) represents ~50% of the water-soluble protein of the mouse corneal epithelial cells and thus, by analogy with the abundant lens crystallins, is considered a corneal crystallin. This study was conducted to examine the developmental pattern and transcriptional activation of <I>Aldh3a1</I> gene expression in the mouse cornea.</p>
<p><scp>methods.</scp> Aldh3a1 mRNA and protein were analyzed by quantitative (Q)-PCR and Western immunoblot analysis. Functional promoter analysis was examined by cotransfecting plasmids containing variable portions of the Aldh3a1 promoter fused to the luciferase reporter gene into COS-7 cells with selected transcription factors. Transcription factor binding sites were identified by electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation assays (ChIP). In situ hybridization and immunohistochemistry were used to assess expression of Aldh3a1, Pax6, and Oct1 in the cornea.</p>
<p><scp>results.</scp> Aldh3a1 expression is temporally regulated in the cornea beginning at birth and increasing 100-fold by 6 weeks of age. Pax6, Oct1, and p300 synergistically activate the Aldh3a1 promoter ~116-fold. One Pax6 and two Oct1 binding sites were identified in vitro and in vivo in the Aldh3a1 promoter fragment analyzed. Pax6 and Oct1 are both present in the nuclei of corneal epithelial cells of the 6-week-old mouse. Finally, a reduction of Aldh3a1 correlated with reduced Pax6 in the corneas of heterozygous <I>Small eye</I> Pax6<sup>+/&ndash;</sup> mice.</p>
<p><scp>conclusions.</scp> Pax6, Oct1, and p300 activate gene expression of the corneal crystallin Aldh3a1 in the mouse. These transcription factors are also implicated in the high expression of crystallin genes in the lens, consistent with the "refracton hypothesis" unifying many aspects of the lens and cornea.</p>
]]></description>
<dc:creator><![CDATA[Davis, J., Davis, D., Norman, B., Piatigorsky, J.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1057</dc:identifier>
<dc:title><![CDATA[[Cornea] Gene Expression of the Mouse Corneal Crystallin Aldh3a1: Activation by Pax6, Oct1, and p300]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1826</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1814</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1827?rss=1">
<title><![CDATA[[Cornea] NFAT5 Induction and Its Role in Hyperosmolar Stressed Human Limbal Epithelial Cells]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1827?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To introduce a tonicity response gene regulator, NFAT (nuclear factor of activated T-cell)-5 and determine its expression mechanism and specific roles in human limbal epithelial cell (HLECs) subjected to hyperosmolar stress.</p>
<p><scp>methods.</scp> NFAT5 expression was determined in various hyperosmolar conditions in HLECs by RT-PCR and Western immunoblot analyses. NFAT5 translocation during hyperosmolar stress was observed by immunocytochemistry. NFAT5-related signal transduction activity was measured on the basis of inhibition of NF-B (nuclear factor-B), and MAPK activity. TNF- and IL-1&beta;, -6, and -8 levels were determined after inhibition of NFAT5 and/or NF-B. Hyperosmotic apoptotic cell death, with or without inhibition of NFAT5, was measured by flow cytometry.</p>
<p><scp>results.</scp> NFAT5 was induced and translocated to the nucleus under conditions of hyperosmolar stress. It was inhibited by SB239063, a p38 MAPK inhibitor. Among the inflammatory cytokines induced in hyperosmolar stress conditions, IL-1&beta; and TNF- levels were significantly reduced after inhibition of NFAT5. Of interest, even after 48 hours of hyperosmolar stress, 45% of HLECs survived. HLEC apoptosis increased markedly as a result of NFAT5 suppression. Moreover, most of the HLECs underwent cell death on dual inhibition of NF-B and NFAT5.</p>
<p><scp>conclusions.</scp> NFAT5 is induced and translocates to the nucleus in HLECs undergoing hyperosmolar stress through activation of p38. IL-1 &beta; and TNF- are induced via NFAT5 activation. Our data collectively indicate that NFAT5 may be an important gene regulator and survival factor in hyperosmolar stressed HLECs.</p>
]]></description>
<dc:creator><![CDATA[Lee, J. H., Kim, M., Im, Y. S., Choi, W., Byeon, S. H., Lee, H. K.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1142</dc:identifier>
<dc:title><![CDATA[[Cornea] NFAT5 Induction and Its Role in Hyperosmolar Stressed Human Limbal Epithelial Cells]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1835</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1827</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1836?rss=1">
<title><![CDATA[[Cornea] Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1836?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To analyze whether tyrosine kinase inhibitors blocking VEGF receptors (<I>PTK787/ZK222584</I> [<I>PTK/ZK</I>] and <I>ZK261991</I> [<I>ZK991</I>]) can inhibit not only hemangiogenesis but also lymphangiogenesis and whether treatment with tyrosine kinase inhibitors after corneal transplantation can improve graft survival.</p>
<p><scp>methods.</scp> Inflammatory corneal neovascularization was induced by corneal suture placement. One treatment group received <I>PTK/ZK</I>, and the other treatment group received <I>ZK991</I>. Corneas were analyzed histomorphometrically for pathologic corneal hemangiogenesis and lymphangiogenesis. The inhibitory effect of tyrosine kinase inhibitors on lymphatic endothelial cells (LECs) in vitro was analyzed with a colorimetric (BrdU) proliferation ELISA. Low-risk allogeneic (C57Bl/6 to BALB/c) corneal transplantations were performed; the treatment group received <I>ZK991</I>, and grafts were graded for rejection (for 8 weeks).</p>
<p><scp>results.</scp> Treatment with tyrosine kinase inhibitors resulted in a significant reduction of hemangiogenesis (<I>PTK/ZK</I> by 30%, <I>P</I> &lt; 0.001; <I>ZK991</I> by 53%, <I>P</I> &lt; 0.001) and lymphangiogenesis (<I>PTK/ZK</I> by 70%, <I>P</I> &lt; 0.001; <I>ZK991</I> by 71%, <I>P</I> &lt; 0.001) in vivo. Inhibition of proliferation of LECs in vitro was also significant and dose dependent (<I>PTK/ZK</I>, <I>P</I> &lt; 0.001; <I>ZK991</I>, <I>P</I> &lt; 0.001). Comparing the survival proportions after corneal transplantation, treatment with <I>ZK991</I> significantly improved graft survival (68% vs. 33%; <I>P</I> &lt; 0.02).</p>
<p><scp>conclusions.</scp> Tyrosine kinase inhibitors blocking VEGF receptors are potent inhibitors not only of inflammatory corneal hemangiogenesis but also lymphangiogenesis in vivo. Tyrosine kinase inhibitors seem to have the ability to restrain the formation of the afferent and efferent arm of the immune reflex arc and are therefore able to promote graft survival after corneal transplantation.</p>
]]></description>
<dc:creator><![CDATA[Hos, D., Bock, F., Dietrich, T., Onderka, J., Kruse, F. E., Thierauch, K.-H., Cursiefen, C.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1314</dc:identifier>
<dc:title><![CDATA[[Cornea] Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1842</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1836</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1843?rss=1">
<title><![CDATA[[Cornea] Zeb1 Mutant Mice as a Model of Posterior Corneal Dystrophy]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1843?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> The zinc finger transcription factor Zeb1 binds to E-box-like sequences and is important for maintaining repression of epithelial specification genes in vivo. Overexpression of Zeb1 in cancer triggers epithelial&ndash;mesenchymal transition, which facilitates metastasis. The mutation of <I>ZEB1</I> in humans is linked to posterior polymorphous corneal dystrophy (PPCD), in which an epithelial transition of the corneal endothelium is associated with abnormal endothelial proliferation. The purpose of this study is to determine whether <I>Zeb1</I> null or heterozygous mice may provide an animal model for PPCD.</p>
<p><scp>methods.</scp> Corneal morphology, protein and mRNA expression, and cell proliferation were compared in wild-type and <I>Zeb1</I> gene knockout mice by immunostaining, real-time PCR, and BrdU incorporation. mRNA expression in isolated embryo fibroblasts derived from wild-type, <I>Zeb1</I> heterozygous, and null mice was analyzed by real-time PCR</p>
<p><scp>results.</scp> <I>Zeb1</I> null mice late in gestation show ectopic expression of epithelial genes in the corneal endothelium and keratocytes, including the basement membrane component COL4A3, which is ectopically expressed by the corneal endothelium in PPCD. These embryos also show abnormal corneal endothelial and keratocyte proliferation, corneal thickening, and corneolenticular and iridocorneal adhesions. Adult <I>Zeb1</I> heterozygous mice exhibit these same corneal defects. The ectopic expression of epithelial genes extended to embryonic fibroblasts derived from <I>Zeb1</I> heterozygous and null mice, suggesting that Zeb1 may have a more general role in the suppression of an epithelial phenotype.</p>
<p><scp>conclusions.</scp> The authors conclude that <I>Zeb1</I> heterozygous and null mice show features of PPCD and thus should provide an animal model for genetic dissection of pathways contributing to the disease.</p>
]]></description>
<dc:creator><![CDATA[Liu, Y., Peng, X., Tan, J., Darling, D. S., Kaplan, H. J., Dean, D. C.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0789</dc:identifier>
<dc:title><![CDATA[[Cornea] Zeb1 Mutant Mice as a Model of Posterior Corneal Dystrophy]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1849</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1843</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1850?rss=1">
<title><![CDATA[[Cornea] A Rabbit Dry Eye Model Induced by Topical Medication of a Preservative Benzalkonium Chloride]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1850?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To establish a rabbit dry eye model with topical medication of the ocular preparation preservative benzalkonium chloride (BAC).</p>
<p><scp>methods.</scp> Sixteen white rabbits were used. One eye of each rabbit was chosen randomly for topical administration of 0.1% BAC twice daily for 14 days. The other untreated eyes served as controls. Schirmer test, fluorescein, and rose bengal staining were performed before and after BAC treatment on days 3, 5, 7, and 14. Conjunctiva impression cytology specimens were collected on days 0, 7, and 14. The rabbits were killed after day 14. Immunofluorescence staining was performed to detect mucin-5 subtype AC (MUC5AC) on conjunctival cryosections. Cornea and conjunctiva structures were evaluated by light and electron microscopy.</p>
<p><scp>results.</scp> Compared with untreated controls, BAC-treated eyes showed significant decreases in Schirmer scores (<I>P</I> = 0.01) and increases in fluorescein scores (<I>P</I> &lt; 0.001) on days 5, 7, and 14. A significant increase in rose bengal scores was noticed as early as day 3 (<I>P</I> = 0.001). Decreases in goblet cell density occurred on days 7 and 14 (<I>P</I> = 0.001). Decreased MUC5AC and histopathologic and ultrastructural disorders of the cornea and conjunctiva were also observed in the BAC group.</p>
<p><scp>conclusions.</scp> These findings demonstrated that an ophthalmic preservative, benzalkonium chloride, induced a dry eye syndrome in rabbits with damage to the cornea and conjunctiva, decreased aqueous tear basal secretion, goblet cell loss, and MUC5AC deficiency. This rabbit model was consistent with human dry eye syndrome in both aqueous tear and mucin deficiency and may be appropriate for studying dry eye syndrome.</p>
]]></description>
<dc:creator><![CDATA[Xiong, C., Chen, D., Liu, J., Liu, B., Li, N., Zhou, Y., Liang, X., Ma, P., Ye, C., Ge, J., Wang, Z.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0720</dc:identifier>
<dc:title><![CDATA[[Cornea] A Rabbit Dry Eye Model Induced by Topical Medication of a Preservative Benzalkonium Chloride]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1856</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1850</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1857?rss=1">
<title><![CDATA[[Cornea] {beta}2-Adrenergic Receptor Signaling Mediates Corneal Epithelial Wound Repair]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1857?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> &beta;-Adrenergic receptor (AR) antagonists are frequently prescribed ophthalmic drugs, yet previous investigations into how catecholamines affect corneal wound healing have yielded conflicting results. With the use of an integrated pharmacologic and genetic approach, the authors investigated how the &beta;-AR impacts corneal epithelial healing.</p>
<p><scp>methods.</scp> Migratory rates of cultured adult murine corneal epithelial (AMCE) cells and in vivo corneal wound healing were examined in &beta;2-AR<sup>+/+</sup> and &beta;2-AR<sup>&ndash;/&ndash;</sup> mice. Signaling pathways were evaluated by immunoblotting.</p>
<p><scp>results.</scp> The &beta;-AR agonist isoproterenol decreased AMCE cell migratory speed to 70% of untreated controls, and this was correlated with a 0.60-fold decrease in levels of activated phospho-ERK (P-ERK). Treatment with the &beta;-AR antagonist (timolol) increased speed 33% and increased P-ERK 2.4-fold (<I>P</I> &lt; 0.05). The same treatment protocols had no effect on AMCE cells derived from &beta;2-AR<sup>&ndash;/&ndash;</sup> mice; all treatment groups showed statistically equivalent migratory speeds and ERK phosphorylation. In &beta;2-AR<sup>+/+</sup> animals, the &beta;-AR agonist (isoproterenol) delayed the rate of in vivo corneal wound healing by 79%, whereas &beta;-AR antagonist (timolol) treatment increased the rate of healing by 16% (<I>P</I> &lt; 0.05) compared with saline-treated controls. In contrast, in the &beta;2-AR<sup>&ndash;/&ndash;</sup> mice, all treatment groups demonstrated equivalent rates of wound healing. Additionally, murine corneal epithelial cell expressed the catecholamine-synthesizing enzyme tyrosine hydroxylase and detectable levels of epinephrine (184.5 pg/mg protein).</p>
<p><scp>conclusions.</scp> The authors provide evidence of an endogenous autocrine catecholamine signaling pathway dependent on an intact &beta;2-AR for the modulation of corneal epithelial wound repair.</p>
]]></description>
<dc:creator><![CDATA[Ghoghawala, S. Y., Mannis, M. J., Pullar, C. E., Rosenblatt, M. I., Isseroff, R. R.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0925</dc:identifier>
<dc:title><![CDATA[[Cornea] {beta}2-Adrenergic Receptor Signaling Mediates Corneal Epithelial Wound Repair]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1863</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1857</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1864?rss=1">
<title><![CDATA[[Cornea] Release of Membrane-Associated Mucins from Ocular Surface Epithelia]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1864?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Three membrane-associated mucins (MAMs)&mdash;MUC1, MUC4, and MUC16&mdash;are expressed at the ocular surface epithelium. Soluble forms of MAMs are detected in human tears, but the mechanisms of their release from the apical cells are unknown. The purpose of this study was to identify physiologic agents that induce ocular surface MAM release.</p>
<p><scp>methods.</scp> An immortalized human corneal-limbal epithelial cell line (HCLE) expressing the same MAMs as native tissue was used. An antibody specific to the MUC16 cytoplasmic tail was developed to confirm that only the extracellular domain is released into the tear fluid or culture media. Effects of agents that have been shown to be present in tears or are implicated in the release or shedding of MAMs in other epithelia (neutrophil elastase, tumor necrosis factor [TNF]), TNF--converting enzyme, and matrix metalloproteinase-7 and -9) were assessed on HCLE cells. HCLE cell surface proteins were biotinylated to measure the efficiency of induced MAM release and surface restoration. Effects of induced release on surface barrier function were measured by rose bengal dye penetrance.</p>
<p><scp>results.</scp> MUC16 in tears and in HCLE-conditioned medium lacked the cytoplasmic tail. TNF induced the release of MUC1, MUC4, and MUC16 from the HCLE surface. Matrix metalloproteinase-7 and neutrophil elastase induced the release of MUC16 but not of MUC1 or MUC4. Neutrophil elastase removed 68% of MUC16, 78% of which was restored to the HCLE cell surface 24 hours after release. Neutrophil elastase-treated HCLE cells showed significantly reduced rose bengal dye exclusion.</p>
<p><scp>conclusions.</scp> Results suggest that the extracellular domains of MUC1, MUC4, and MUC16 can be released from the ocular surface by agents in tears. Neutrophil elastase and TNF, present in higher amounts in the tears of patients with dry eye, may cause MAM release, allowing rose bengal staining.</p>
]]></description>
<dc:creator><![CDATA[Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S., Gipson, I. K.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1081</dc:identifier>
<dc:title><![CDATA[[Cornea] Release of Membrane-Associated Mucins from Ocular Surface Epithelia]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1871</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1864</prism:startingPage>
<prism:section>Cornea</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1872?rss=1">
<title><![CDATA[[Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology] Duration of Binocular Decorrelation Predicts the Severity of Latent (Fusion Maldevelopment) Nystagmus in Strabismic Macaque Monkeys]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1872?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Infantile esotropia is linked strongly to latent fixation nystagmus (LN) in human infants, but many features of this comorbidity are unknown. The purpose of this study was to determine how the duration of early-onset strabismus (or timeliness of repair) affects the prevalence of LN in a primate model.</p>
<p><scp>methods.</scp> Optical strabismus was created in infant macaques by fitting them with prism goggles on day 1 of life. The goggles were removed after 3 (<I>n</I> = 2), 12 (<I>n</I> = 1) or 24 weeks (<I>n</I> = 3), emulating surgical repair of strabismus in humans at 3, 12, and 24 months of age, respectively. Eye movements were recorded by using binocular search coils.</p>
<p><scp>results.</scp> Each animal in the 12- and 24-week groups exhibited LN and manifest LN, normal spatial vision (no amblyopia), and constant esotropia. The 3-week duration monkeys had stable fixation (no LN) and normal alignment indistinguishable from control animals. In affected monkeys, the longer the duration of binocular decorrelation, the greater the LN: mean slow-phase eye velocity (SPEV) in the 24-week animals was three times greater than that in the 12-week monkey (<I>P</I> = 0.03); mean LN intensity in the 24-week monkeys was three times greater than that in the 12-week monkey (<I>P</I> = 0.03).</p>
<p><scp>conclusions.</scp> Binocular decorrelation in primates during an early period of fusion development causes permanent gaze instability when the duration exceeds the equivalent of 3 months in humans. These findings support the conclusion that early correction of infantile strabismus promotes normal development of cerebral gaze-holding pathways.</p>
]]></description>
<dc:creator><![CDATA[Richards, M., Wong, A., Foeller, P., Bradley, D., Tychsen, L.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1375</dc:identifier>
<dc:title><![CDATA[[Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology] Duration of Binocular Decorrelation Predicts the Severity of Latent (Fusion Maldevelopment) Nystagmus in Strabismic Macaque Monkeys]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1878</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1872</prism:startingPage>
<prism:section>Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1879?rss=1">
<title><![CDATA[[Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology] In Vivo Retinal Nerve Fiber Layer Thickness Measured by Optical Coherence Tomography Predicts Visual Recovery after Surgery for Parachiasmal Tumors]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1879?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Restoration of visual function after neurosurgery for parachiasmal tumors is variable and unpredictable. The current study was conducted to determine whether in vivo retinal nerve fiber layer (RNFL) thickness measurements predict the visual recovery of such patients.</p>
<p><scp>methods.</scp> Forty patients undergoing surgical resection of parachiasmal lesions were prospectively assessed before surgery with a neuro-ophthalmic examination, involving standard automated visual field (VF) testing and optical coherence tomography (OCT) measurements of RNFL thickness, which was the prespecified marker for axonal loss. Tests were repeated within 6 weeks after surgery.</p>
<p><scp>results.</scp> Thinner preoperative RNFL thickness was associated with worse visual acuity (VA) and VF mean deviation (MD). Patients with normal preoperative RNFL had significant improvement in mean VA after surgery, from 20/40 to 20/25 (<I>P</I> = 0.028), whereas patients with thin RNFL did not improve (20/80 to 20/60, <I>P</I> = 0.177). Eyes with normal RNFL showed improvement in MD (&ndash;7.0 dB before surgery, &ndash;3.5 dB after surgery, <I>P</I> = 0.0007) unlike eyes with thin RNFLs, which had no significant improvement after surgery (&ndash;15.3 dB before and &ndash;13.3 dB after surgery, <I>P</I> = 0.191). RNFL thickness increased by 1% after surgery among all eyes (<I>P</I> = 0.04). Eyes with severe VF defects (MD &le; &ndash;10 dB) but normal preoperative RNFL thickness showed a postoperative improvement in MD of 14.6 dB compared with 1.6 dB (<I>P</I> &lt; 0.0001) in eyes with thin RNFL before surgery, despite no difference in MD before surgery (normal RNFL MD, &ndash;22.3 dB; thin RNFL MD, &ndash;20.8 dB; <I>P</I> = 0.7).</p>
<p><scp>conclusions.</scp> Patients who have objectively measurable RNFL loss at the time of surgery for chiasmal compressive lesions are less likely to have return of VA or VF after surgery.</p>
]]></description>
<dc:creator><![CDATA[Danesh-Meyer, H. V., Papchenko, T., Savino, P. J., Law, A., Evans, J., Gamble, G. D.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1127</dc:identifier>
<dc:title><![CDATA[[Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology] In Vivo Retinal Nerve Fiber Layer Thickness Measured by Optical Coherence Tomography Predicts Visual Recovery after Surgery for Parachiasmal Tumors]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1885</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1879</prism:startingPage>
<prism:section>Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1886?rss=1">
<title><![CDATA[[Glaucoma] Gene Expression Profiles of Human Trabecular Meshwork Cells Induced by Triamcinolone and Dexamethasone]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1886?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Triamcinolone acetonide (TA) and dexamethasone (DEX) are corticosteroids commonly used for ocular inflammation, but both can cause ocular hypertension. In this study, the differential gene expression profile of human trabecular meshwork (TM) cells in response to treatment by TA in comparison with DEX was investigated.</p>
<p><scp>methods.</scp> Total RNA was extracted from cultured human TM cells treated with TA or DEX and used for microarray gene expression analysis. The microarray experiments were repeated three times. Differentially expressed genes were identified by an empiric Bayes approach and confirmed by real-time quantitative PCR.</p>
<p><scp>results.</scp> TA (0.1 mg/mL) treatment resulted in 15 genes upregulated and 12 genes downregulated, whereas 1 mg/mL TA resulted in 36 genes upregulated and 21 genes downregulated. These genes were mainly associated with acute-phase response, cell adhesion, cell cycle and growth, growth factor, ion binding, metabolism, proteolysis and transcription factor. Two genes, <I>MYOC</I> and <I>GAS1</I>, were upregulated, and three genes, <I>SENP1</I>, <I>ZNF343</I>, and <I>SOX30</I>, were downregulated by both TA and DEX treatment. Eight differentially expressed genes were located in known primary open-angle glaucoma (POAG) loci, including <I>MYOC</I>, <I>SOAT1</I>, <I>CYP27A1</I>, <I>SPOCK</I>, <I>SEMA6A</I>, <I>EGR1</I>, <I>GAS1</I>, and <I>ATP10A</I>.</p>
<p><scp>conclusions.</scp> Differential gene expression profiles of human TM cells treated by TA and DEX, and a dosage effect by TA, were revealed by microarray technology. TA and DEX treatment shared several differentially expressed genes, suggesting a common mechanism to cause ocular hypertension. Some differentially expressed genes located in the known POAG loci are potential candidates for glaucoma genes.</p>
]]></description>
<dc:creator><![CDATA[Fan, B. J., Wang, D. Y., Tham, C. C. Y., Lam, D. S. C., Pang, C. P.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0414</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Gene Expression Profiles of Human Trabecular Meshwork Cells Induced by Triamcinolone and Dexamethasone]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1897</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1886</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1898?rss=1">
<title><![CDATA[[Glaucoma] Comparison of HRT-3 Glaucoma Probability Score and Subjective Stereophotograph Assessment for Prediction of Progression in Glaucoma]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1898?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To assess whether baseline Glaucoma Probability Score (GPS; HRT-3; Heidelberg Engineering, Dossenheim, Germany) results are predictive of progression in patients with suspected glaucoma. The GPS is a new feature of the confocal scanning laser ophthalmoscope that generates an operator-independent, three-dimensional model of the optic nerve head and gives a score for the probability that this model is consistent with glaucomatous damage.</p>
<p><scp>methods.</scp> The study included 223 patients with suspected glaucoma during an average follow-up of 63.3 months. Included subjects had a suspect optic disc appearance and/or elevated intraocular pressure, but normal visual fields. Conversion was defined as development of either repeatable abnormal visual fields or glaucomatous deterioration in the appearance of the optic disc during the study period. The association between baseline GPS and conversion was investigated by Cox regression models.</p>
<p><scp>results.</scp> Fifty-four (24.2%) eyes converted. In multivariate models, both higher values of GPS global and subjective stereophotograph assessment (larger cup&ndash;disc ratio and glaucomatous grading) were predictive of conversion: adjusted hazard ratios (95% CI): 1.31 (1.15&ndash;1.50) per 0.1 higher global GPS, 1.34 (1.12&ndash;1.62) per 0.1 higher CDR, and 2.34 (1.22&ndash;4.47) for abnormal grading, respectively. No significant differences (<I>P</I> &gt; 0.05 for all comparisons) were found between the <I>c</I>-index values (equivalent to area under ROC curve) for the multivariate models (0.732, 0.705, and 0.699, respectively).</p>
<p><scp>conclusions.</scp> GPS values were predictive of conversion in our population of patients with suspected glaucoma. Further, they performed as well as subjective assessment of the optic disc. These results suggest that GPS could potentially replace stereophotograph as a tool for estimating the likelihood of conversion to glaucoma.</p>
]]></description>
<dc:creator><![CDATA[Alencar, L. M., Bowd, C., Weinreb, R. N., Zangwill, L. M., Sample, P. A., Medeiros, F. A.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0111</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Comparison of HRT-3 Glaucoma Probability Score and Subjective Stereophotograph Assessment for Prediction of Progression in Glaucoma]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1906</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1898</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1907?rss=1">
<title><![CDATA[[Glaucoma] Evaluation of Quality of Life and Priorities of Patients with Glaucoma]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1907?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To investigate the quality of life and priorities of patients with glaucoma.</p>
<p><scp>methods.</scp> Patients diagnosed with glaucoma and no other ocular comorbidity were consecutively recruited. Clinical information was collected. Participants were asked to complete three questionnaires: EuroQuol (EQ-5D), time tradeoff (TTO), and choice-based conjoint analysis. The latter used five-attribute outcomes: (1) reading and seeing detail, (2) peripheral vision, (3) darkness and glare, (4) household chores, and (5) outdoor mobility. Visual field loss was estimated by using binocular integrated visual fields (IVFs).</p>
<p><scp>results.</scp> Of 84 patients invited to participate, 72 were enrolled in the study. The conjoint utilities showed that the two main priorities were "reading and seeing detail" and "outdoor mobility." This rank order was stable across all segmentations of the data by demographic or visual state. However, the relative emphasis of these priorities changed with increasing visual field loss, with concerns for central vision increasing, whereas those for outdoor mobility decreased. Two subgroups of patients with differing priorities on the two main attributes were identified. Only 17% of patients (those with poorer visual acuity) were prepared to consider TTO. A principal component analysis revealed relatively independent components (i.e., low correlations) between the three different methodologies for assessing quality of life.</p>
<p><scp>conclusions.</scp> Assessments of quality of life using different methodologies have been shown to produce different outcomes with low intercorrelations between them. Only a minority of patients were prepared to trade time for a return to normal vision. Conjoint analysis showed two subgroups with different priorities. Severity of glaucoma influenced the relative importance of priorities.</p>
]]></description>
<dc:creator><![CDATA[Aspinall, P. A., Johnson, Z. K., Azuara-Blanco, A., Montarzino, A., Brice, R., Vickers, A.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0559</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Evaluation of Quality of Life and Priorities of Patients with Glaucoma]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1915</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1907</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1916?rss=1">
<title><![CDATA[[Glaucoma] Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1916?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To search for and validate potential molecular pathogenic mechanisms in the trabecular meshwork (TM) responsible for the elevated intraocular pressure (IOP) associated with glaucoma.</p>
<p><scp>methods.</scp> Gene chip arrays were used to identify differential gene expression in glaucomatous TM tissues. Serum amyloid A (SAA) upregulation was subsequently confirmed with quantitative PCR (QPCR) and ELISA. The effect of SAA on gene expression of cultured human TM cells was tested with gene chip arrays and verified with ELISA, and its effect on IOP was evaluated in the human ocular perfusion organ culture.</p>
<p><scp>results.</scp> Microarray analysis showed that the expression of SAA2 was increased in TM tissues from donors with glaucoma. This finding was subsequently confirmed by QPCR. The SAA mRNA levels were increased in glaucoma TM tissues by more than 5-fold (<I>P</I> &lt; 0.05) and in cultured TM cells derived from donors with glaucoma by 25-fold (<I>P</I> &lt; 0.05) compared with controls. SAA protein levels in the TM of glaucoma patients were also significantly (<I>P</I> &lt; 0.05) elevated by 2.9-fold. Treatment of cultured human TM cells with recombinant SAA affected gene expression, including a 22-fold up-regulation of interleukin-8 (<I>P</I> &lt; 0.001). SAA increased IOP by approximately 40% (<I>P</I> &lt; 0.05) in the human ocular perfusion organ culture without any observable changes in the morphology of the tissues involved in aqueous outflow.</p>
<p><scp>conclusions.</scp> These findings indicate that SAA, which is an acute-phase apolipoprotein that plays important roles in infection, inflammation, and tissue repair, may contribute to the pathogenic changes to the TM in glaucoma.</p>
]]></description>
<dc:creator><![CDATA[Wang, W.-H., McNatt, L. G., Pang, I.-H., Hellberg, P. E., Fingert, J. H., McCartney, M. D., Clark, A. F.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1104</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1923</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1916</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1924?rss=1">
<title><![CDATA[[Glaucoma] Caffeine Consumption and the Risk of Primary Open-Angle Glaucoma: A Prospective Cohort Study]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1924?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To investigate whether caffeine, which transiently increases intraocular pressure (IOP) is associated with the risk of primary open-angle glaucoma (POAG).</p>
<p><scp>methods.</scp> A total of 79,120 women from 1980 to 2004 and 42,052 men from 1986 to 2004, who were 40+ years of age, did not have POAG, and reported undergoing eye examinations, were observed. Information on caffeine consumption, potential confounders, and POAG diagnoses were repeatedly updated in validated follow-up questionnaires. One thousand eleven incident POAG cases were confirmed with medical record review. Cohort-specific and pooled analyses across cohorts were conducted to calculate multivariate rate ratios (RRs).</p>
<p><scp>results.</scp> Compared with daily intake of less than 150 mg, the pooled multivariate RRs were 1.05 (95% confidence interval [CI], 0.89&ndash;1.25) for consumption of 150 to 299 mg/d, 1.19 (95% CI, 0.99&ndash;1.43) for 300 to 449 mg/d, 1.13 (95% CI, 0.89&ndash;1.43) for 450 to 559 mg/d, and 1.17 (95% CI, 0.90&ndash;1.53) for 600+ mg/d (<I>P</I> for trend = 0.11). However, for consumption of five or more cups of caffeinated coffee daily, the RR was 1.61 (95% CI, 1.00&ndash;2.59; <I>P</I> for trend = 0.02); tea or caffeinated cola intake were not associated with risk. Greater caffeine intake was more adversely associated with POAG among those reporting a family history of glaucoma, particularly in relation to POAG with elevated IOP (<I>P</I> for trend = 0.0009; <I>P</I> interaction = 0.04).</p>
<p><scp>conclusions.</scp> Overall caffeine intake was not associated with increased risk of POAG. However, in secondary analyses, caffeine appeared to elevate risk of high-tension POAG among those with a family history of glaucoma. This result may be due to chance, but warrants further study.</p>
]]></description>
<dc:creator><![CDATA[Kang, J. H., Willett, W. C., Rosner, B. A., Hankinson, S. E., Pasquale, L. R.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1425</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Caffeine Consumption and the Risk of Primary Open-Angle Glaucoma: A Prospective Cohort Study]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1931</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1924</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1932?rss=1">
<title><![CDATA[[Glaucoma] Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1932?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To developed a genetic mouse model of primary open-angle glaucoma induced by expression of mutated human myocilin in transgenic mice and to test whether expression of mutated human myocilin in the eye angle structures produces more significant damage to the eye than does mutated mouse myocilin.</p>
<p><scp>methods.</scp> Recombineering in <I>Escherichia coli</I> was used to introduce the Tyr437His point mutation into a BAC carrying the full-length human <I>MYOCILIN</I> (<I>MYOC</I>) gene and long flanking regions. This BAC was used to produce transgenic mice. The expression of myocilin in the iridocorneal angle tissues and aqueous humor was studied by immunohistochemistry and Western blot analysis. Intraocular pressure was measured noninvasively with a fiber optic transducer. Retinal ganglion cells were retrograde labeled with fluorescent gold, and counted 5 days after labeling.</p>
<p><scp>results.</scp> BAC transgenic mice expressed elevated levels of myocilin in tissues of the iridocorneal angle. Expression of mutated myocilin induced its intracellular accumulation and prevented secretion of both mutated and wild-type myocilin into the aqueous humor. Transgenic mice demonstrated a moderate elevation of intraocular pressure, which was more pronounced at night than in daytime. In the peripheral retina, transgenic mice lost 20% of the retinal ganglion cells and 55% of large retinal ganglion cells. Axonal degeneration was observed at the periphery of the optic nerve.</p>
<p><scp>conclusions.</scp> Expression of equivalent levels of mutated human or mouse myocilin in the eyes of transgenic mice produce comparable pathologic changes that are similar to those observed in patients with glaucoma.</p>
]]></description>
<dc:creator><![CDATA[Zhou, Y., Grinchuk, O., Tomarev, S. I.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1339</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1939</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1932</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1940?rss=1">
<title><![CDATA[[Glaucoma] Quantification of Retinal Transneuronal Degeneration in Human Glaucoma: A Novel Multiphoton-DAPI Approach]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1940?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Glaucoma is presumed to result in the selective loss of retinal ganglion cells. In many neural systems, this loss would initiate a cascade of transneuronal degeneration. The quantification of changes in neuronal populations in the middle layers of the retina can be difficult with conventional histologic techniques. A method was developed based on multiphoton imaging of 4',6'-diamino-2-phenylindole (DAPI)&ndash;stained tissue to quantify neuron loss in postmortem human glaucomatous retinas.</p>
<p><scp>methods.</scp> Retinas from normal and glaucomatous eyes fixed in 4% paraformaldehyde were incubated at 4&deg;C overnight in DAPI solution. DAPI-labeled neurons at different levels of the retina were imaged by multiphoton confocal microscopy. Algorithms were developed for the automated identification of neurons in the retinal ganglion cell layer (RGCL), inner nucleus layer (INL), and outer nuclear layer (ONL).</p>
<p><scp>results.</scp> In glaucomatous retinas, the mean density of RGCs within 4 mm eccentricity was reduced by approximately 45%, with the greatest RGC loss occurring in a region that corresponds to the central 6&deg; to 14&deg; of vision. Significant neuron loss in the INL and ONL was also seen at 2 to 4 mm and 2 to 3 mm eccentricities, respectively. The ratios of neuron densities in the INL and ONL relative to the RGCL (INL/RGC and ONL/RGC, respectively) were found to increase significantly at 3 to 4 mm eccentricity.</p>
<p><scp>conclusions.</scp> The data confirm that the greatest neuronal loss occurs in the RGCL in human glaucoma. Neuronal loss was also observed in the outer retinal layers (INL and ONL) that correlated spatially with changes in the RGCL. Further work is necessary to confirm whether these changes arise from transneuronal degeneration.</p>
]]></description>
<dc:creator><![CDATA[Lei, Y., Garrahan, N., Hermann, B., Becker, D. L., Hernandez, M. R., Boulton, M. E., Morgan, J. E.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0735</dc:identifier>
<dc:title><![CDATA[[Glaucoma] Quantification of Retinal Transneuronal Degeneration in Human Glaucoma: A Novel Multiphoton-DAPI Approach]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1945</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1940</prism:startingPage>
<prism:section>Glaucoma</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1946?rss=1">
<title><![CDATA[[Immunology and Microbiology] Repertoire Analysis and New Pathogenic Epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) Mice]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1946?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Interphotoreceptor retinoid binding protein (IRBP) is the major uveitogenic retinal antigen eliciting experimental autoimmune uveoretinitis (EAU) in mice. The most frequently used mouse strains are B10.RIII and C57BL/6, but to date only one uveitogenic epitope for each has been identified. The purpose of this study was to identify and characterize additional uveitogenic epitopes in B10.RIII and C57BL/6 mice and to compare epitope recognition in wild-type versus IRBP-deficient mice on both backgrounds.</p>
<p><scp>methods.</scp> Mice were immunized with IRBP. Spleen cells were stimulated in culture with overlapping peptides representing the entire IRBP molecule, and lymphocyte proliferative responses were measured. Peptides determined to be immunodominant were used to immunize mice for EAU. Cytokine profile and proliferation of the CD4 versus CD8 subsets were analyzed for the most pathogenic peptides.</p>
<p><scp>results.</scp> Two new major pathogenic epitopes were identified in WT C57BL/6 mice, residues 461-480 and 651-670. These epitopes induced EAU of severity similar to that induced by the previously known peptide, 1-20. Several other peptides elicited mild disease with lower incidence. Some peptides elicited EAU only in WT recipients of IRBP KO splenocytes. In the B10.RIII strain, two major new uveitogenic peptides were identified, 171-190 and 541-560, and several others elicited moderate disease. Unlike in C57BL/6 mice, adoptive transfer of WT B10.RIII with IRBP KO splenocytes did not reveal additional uveitogenic epitopes. Both CD4 and CD8 lymphocyte subsets proliferated to pathogenic peptides.</p>
<p><scp>conclusions.</scp> Several new pathogenic peptides of IRBP were identified in C57BL/6 and B10.RIII mice. Differences in epitope recognition between WT and IRBP KO mice were observed in C57BL/6 mice, but not in B10.RIII mice, suggesting more extensive culling of the repertoire in C57BL/6 mice by endogenously expressed IRBP.</p>
]]></description>
<dc:creator><![CDATA[Cortes, L. M., Mattapallil, M. J., Silver, P. B., Donoso, L. A., Liou, G. I., Zhu, W., Chan, C.-C., Caspi, R. R.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0868</dc:identifier>
<dc:title><![CDATA[[Immunology and Microbiology] Repertoire Analysis and New Pathogenic Epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) Mice]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1956</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1946</prism:startingPage>
<prism:section>Immunology and Microbiology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1957?rss=1">
<title><![CDATA[[Immunology and Microbiology] Differentially Expressed Genes in MHC-Compatible Rat Strains That Are Susceptible or Resistant to Experimental Autoimmune Uveitis]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1957?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Experimental autoimmune uveitis (EAU) is an established model for immune-mediated human uveitis. Although several genes from major histocompatibility complex (MHC) loci have been shown to play a role in uveitis, little is known about the role of non-MHC genes in the pathogenesis of EAU. Several non-MHC genes have been implicated in the pathogenesis of various autoimmune diseases. The primary objective of this study was to identify the non-MHC genes involved in the pathogenesis of EAU, to identify potential drug targets and possibly to target their protein products for immunotherapy.</p>
<p><scp>methods.</scp> EAU was induced in the susceptible (Lewis; LEW) or resistant (Fischer 344; F344) rats that have identical MHC class II haplotype. Draining lymph node cells were obtained during the innate and adaptive phase of the immune response, and the pattern of gene expression was evaluated using microarray technology. Differentially expressed genes were validated at mRNA and protein levels using various methods.</p>
<p><scp>results.</scp> Susceptibility to EAU was associated with an increased expression of numerous non-MHC genes such as Th1-type cytokines and chemokines, antiapoptotic factors, hormones, and neurotransmitters and a downregulation of selected adhesion molecules. In this study a combined genetic-genomic approach was used to identify different patterns of gene expression associated with the sensitization and effector phase of EAU pathogenesis.</p>
<p><scp>conclusions.</scp> The data demonstrate that the differential expression of several non-MHC genes is associated with the mechanism of uveitis.</p>
]]></description>
<dc:creator><![CDATA[Mattapallil, M. J., Augello, A., Cheadle, C., Teichberg, D., Becker, K. G., Chan, C.-C., Mattapallil, J. J., Pennesi, G., Caspi, R. R.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1295</dc:identifier>
<dc:title><![CDATA[[Immunology and Microbiology] Differentially Expressed Genes in MHC-Compatible Rat Strains That Are Susceptible or Resistant to Experimental Autoimmune Uveitis]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1970</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1957</prism:startingPage>
<prism:section>Immunology and Microbiology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1971?rss=1">
<title><![CDATA[[Immunology and Microbiology] Eubacterial PCR for Bacterial Detection and Identification in 100 Acute Postcataract Surgery Endophthalmitis]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1971?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To evaluate eubacterial PCR compared with conventional cultures for detection and identification of bacterial agents in ocular samples from patients with acute postcataract endophthalmitis.</p>
<p><scp>methods.</scp> Broad-range eubacterial PCR amplification was used, followed by direct DNA sequencing in ocular samples (aqueous humor, vitreous samples from tap or vitrectomy) from 100 consecutive patients presenting with acute postcataract endophthalmitis. Bacterial cultures were performed on the same ocular samples by using traditional methods (brain-heart infusion broth).</p>
<p><scp>results.</scp> At the time of admission, the detection rate was not significantly different between cultures and PCR (38.2% for cultures versus 34.6% for PCR in aqueous humor samples; 54% versus 57% in vitreous from a vitreous tap). In contrast, in the vitreous obtained from vitrectomy, after intravitreous injection of antibiotics, PCR detected bacteria in 70% of the cases, compared with 9% in cultures. By combining PCR and cultures, bacterial identification was obtained in 47% of aqueous humor samples at admission, in 68% of vitreous samples from a vitreous tap at admission, and in 72% of vitreous samples from pars plana vitrectomy. Gram-positive bacteria predominated (94.3%). The concordance between cultures and PCR was 100%. The contamination rate was 2%.</p>
<p><scp>conclusions.</scp> Cultures and eubacterial PCR are complementary techniques for bacterial identification in eyes with acute postcataract endophthalmitis. PCR technique was needed for identification of the involved microbial pathogen in 25% of all the cases. Eubacterial PCR is more effective than cultures in detecting bacteria in vitreous samples from patients with previous intravitreous administration of antibiotics.</p>
]]></description>
<dc:creator><![CDATA[Chiquet, C., Cornut, P.-L., Benito, Y., Thuret, G., Maurin, M., Lafontaine, P.-O., Pechinot, A., Palombi, K., Lina, G., Bron, A., Denis, P., Carricajo, A., Creuzot, C., Romanet, J.-P., Vandenesch, F., for the French Institutional Endophthalmitis Study (FRIENDS) Group]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1377</dc:identifier>
<dc:title><![CDATA[[Immunology and Microbiology] Eubacterial PCR for Bacterial Detection and Identification in 100 Acute Postcataract Surgery Endophthalmitis]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1978</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1971</prism:startingPage>
<prism:section>Immunology and Microbiology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1979?rss=1">
<title><![CDATA[[Immunology and Microbiology] Interleukin-10 Gene Polymorphism (-1082G/A) is Associated with Toxoplasmic Retinochoroiditis]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1979?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Experimental data have demonstrated a relevant role for IL-10, an anti-inflammatory cytokine, in the modulation of acute ocular toxoplasmosis. Therefore, this study was conducted to investigate the possible association between an <I>IL10</I> gene polymorphism at position &ndash;1082 and toxoplasmic retinochoroiditis (TR) in humans.</p>
<p><scp>methods.</scp> One hundred patients with diagnosed TR were recruited from the Uveitis Section, Federal University of Minas Gerais. For comparison, one hundred healthy blood donors with positive serology for toxoplasmosis and without retinal signs of previous TR were included in the study. Genomic DNA was obtained from oral swabs of individuals and amplified using polymerase chain reaction (PCR) with specific primers flanking the locus &ndash;1082 of <I>IL10</I> (&ndash;1082G/A). PCR products were subjected to restriction endonuclease digestion and analyzed by polyacrylamide gel electrophoresis, to distinguish allele G and A of the <I>IL-10</I> gene, allowing the detection of the polymorphism and determination of genotypes.</p>
<p><scp>results.</scp> There was a significant difference in the genotype distribution between TR patients and control subjects (<sup>2</sup> = 6.33, <I>P</I> = 0.04). Carriers of the <I>IL10</I> &ndash;1082 A allele (AA+AG genotypes) were more often patients with TR than control subjects (<sup>2</sup> = 5.97, <I>P</I> = 0.01, OR, 2.55; 95% CI, 1.11 &lt; OR &lt; 5.55). In a subgroup analysis, there was no significant difference in genotypes and allele carriage regarding visual acuity, involvement of both eyes and TR recurrence.</p>
<p><scp>conclusions.</scp> This study suggests that the genotypes related with a low production of IL-10 may be associated with the occurrence of TR.</p>
]]></description>
<dc:creator><![CDATA[Cordeiro, C. A., Moreira, P. R., Andrade, M. S., Dutra, W. O., Campos, W. R., Orefice, F., Teixeira, A. L.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1393</dc:identifier>
<dc:title><![CDATA[[Immunology and Microbiology] Interleukin-10 Gene Polymorphism (-1082G/A) is Associated with Toxoplasmic Retinochoroiditis]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1982</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1979</prism:startingPage>
<prism:section>Immunology and Microbiology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1983?rss=1">
<title><![CDATA[[Immunology and Microbiology] Measurement of Factor H Variants in Plasma Using Variant-Specific Monoclonal Antibodies: Application to Assessing Risk of Age-Related Macular Degeneration]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1983?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> The Y402H polymorphism in the complement regulator factor H (fH) is strongly associated with age-related macular degeneration (AMD) across diverse populations. Persons homozygous for histidine at this position have up to 12-fold greater risk for AMD than those homozygous for tyrosine. Knowledge of fH-Y402H status is, therefore, valuable in predicting risk and focusing preventive measures in the elderly. This knowledge requires genetic analysis, which is unavailable in most laboratories and which provides no information about the levels of fH protein, a putative linked determinant of disease risk.</p>
<p><scp>methods.</scp> The authors describe novel monoclonal antibodies that distinguish the two fH allelic variants in plasma. ELISA with these antibodies not only reliably identifies the fH-Y402H status, confirmed by genotyping, but also quantifies the concentration of total fH and the fH-Y402 and fH-H402 variants.</p>
<p><scp>results.</scp> In young adult control subjects, mean fH concentration was 233 mg/L. In elderly control subjects, mean fH concentration was 269 mg/L, whereas in a matching AMD cohort, mean fH concentration was 288 mg/L. Total fH concentration was similar in each subgroup of young and elderly control subjects; however, in the AMD group, fH concentration was significantly higher in the heterozygous subgroup. Measurement of the two variants in this subgroup showed that both were elevated to a similar degree.</p>
<p><scp>conclusions.</scp> The novel monoclonal antibody MBI-7 was used to develop a robust assay for measurement of fH and the variants in plasma. The simplicity of the assay means that it may be used by any clinical laboratory to identify polymorphic status and to quantify plasma levels in persons at risk for AMD.</p>
]]></description>
<dc:creator><![CDATA[Hakobyan, S., Harris, C. L., Tortajada, A., Goicochea de Jorge, E., Garcia-Layana, A., Fernandez-Robredo, P., Rodriguez de Cordoba, S., Morgan, B. P.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1523</dc:identifier>
<dc:title><![CDATA[[Immunology and Microbiology] Measurement of Factor H Variants in Plasma Using Variant-Specific Monoclonal Antibodies: Application to Assessing Risk of Age-Related Macular Degeneration]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1990</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1983</prism:startingPage>
<prism:section>Immunology and Microbiology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1991?rss=1">
<title><![CDATA[[Lens] Free and Bound Water in Normal and Cataractous Human Lenses]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1991?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To analyze free and total water in human normal and cataractous lenses.</p>
<p><scp>methods.</scp> Thermogravimetric analysis was used to determine total water, and differential scanning calorimetry was used for free water.</p>
<p><scp>results.</scp> In normal human lenses, the total water content of the nucleus remained unchanged with age, but the state of the water altered. The ratio of free to bound water increased steadily throughout adult life. In a 20-year-old person, there was approximately one bound water molecule for each free water molecule in the lens center, whereas in a 70- to 80-year-old person, there were two free water molecules for each bound water molecule. This conversion of bound to free water does not appear to be simply a consequence of the aggregation of soluble crystallins into high molecular weight aggregates because studies with intact pig lenses, in which such processes were facilitated by heat, did not show similar changes. The region of the lens in which the barrier to diffusion develops at middle age corresponds to a transition zone in which the protein concentration is intermediate between that of the cortex and the nucleus. In cataractous lenses, the free-to-bound water ratio was not significantly different from that of age-matched normal lenses; however, total water content in the center of advanced nuclear cataractous lenses was slightly lower than in normal lenses.</p>
<p><scp>conclusions.</scp> As the human lens ages, bound water is progressively changed to free water. Advanced nuclear cataract may be associated with lower total hydration of the lens nucleus.</p>
]]></description>
<dc:creator><![CDATA[Heys, K. R., Friedrich, M. G., Truscott, R. J. W.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1151</dc:identifier>
<dc:title><![CDATA[[Lens] Free and Bound Water in Normal and Cataractous Human Lenses]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>1997</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1991</prism:startingPage>
<prism:section>Lens</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/1998?rss=1">
<title><![CDATA[[Lens] Downregulation of MMP-2 and -9 by Proteasome Inhibition: A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular Opacification]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/1998?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> The proliferation, epithelial&ndash;mesenchymal transition (EMT), and migration of residual lens epithelial cells (LECs) after cataract surgery leads to the development of posterior capsular opacification (PCO). The authors have shown that proteasome inhibition suppresses LEC proliferation and EMT. The present study investigates the prevention of LEC migration by proteasome inhibition through the suppression of matrix metalloproteinase (MMP) expression and activity.</p>
<p><scp>methods.</scp> HLE B-3 and primary human LEC migration assays were performed using polycarbonate membrane inserts and 20% fetal bovine serum (FBS) as chemoattractant. Cultured cells were treated with 1 ng TGF-&beta;<SUB>2</SUB>, with or without MG132 (proteasome inhibitor) or GM 6001 (MMP inhibitor). Capsular bags with intraocular lenses (IOLs) were prepared from human donor eyes and cultured in serum-free DMEM. The capsular bags were then treated with 1 or 10 ng/mL TGF-&beta;<SUB>2</SUB>, with or without MG132 (2.5 or 10 &micro;M, respectively). The medium was sampled and replaced every 2 days and analyzed for MMP-2 and -9 activities by SDS-PAGE zymography. Protein and RNA expression were analyzed by Western blotting and RT-PCR, respectively.</p>
<p><scp>results.</scp> Proteasome inhibition blocks LEC migration in HLE B-3 and primary human LECs. To further evaluate the mechanism of decrease in LEC migration by proteasome inhibition, the authors measured MMP-2 mRNA and protein expression and MMP-2 and -9 activities. In HLE B-3 cells, TGF-&beta;<SUB>2</SUB> increased MMP-2 mRNA and protein levels; these increases were inhibited by MG132 cotreatment. Medium from HLE B-3 cultures showed MMP-2 and -9 activities, which were induced by TGF-&beta;<SUB>2</SUB> treatment and inhibited by MG132 co-treatment. TGF-&beta;<SUB>2</SUB> treatment also increased MMP-2 and -9 activities in IOL capsular bag cultures; these were progressively decreased by proteasome inhibition.</p>
<p><scp>conclusions.</scp> Proteasome inhibition decreases LEC migration. This inhibition is correlated with decreased MMP-2 and -9 activities, observed both with and without TGF-&beta;<SUB>2</SUB> treatment. These findings support proteasome inhibition as a therapeutic strategy to prevent PCO.</p>
]]></description>
<dc:creator><![CDATA[Awasthi, N., Wang-Su, S. T., Wagner, B. J.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0624</dc:identifier>
<dc:title><![CDATA[[Lens] Downregulation of MMP-2 and -9 by Proteasome Inhibition: A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular Opacification]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2003</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>1998</prism:startingPage>
<prism:section>Lens</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2004?rss=1">
<title><![CDATA[[Lens] Pentacam Tomograms: A Novel Method for Quantification of Posterior Capsule Opacification]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2004?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To develop and validate a method to quantify posterior capsule opacification (PCO) in eyes after cataract surgery and intraocular lens implantation using Scheimpflug Pentacam tomograms and compare its validity with slit lamp retroillumination image analysis.</p>
<p><scp>methods.</scp> One hundred twenty-four pseudophakic eyes of 124 patients were divided into two groups. Group 1 consisted of 40 eyes with visually significant PCO, and group 2 consisted of 84 eyes without visually significant PCO. Pentacam Imaging was performed after full mydriasis using the 50-scan acquisition protocol, and high-resolution tomograms were reconstructed and analyzed using ImageJ freeware. Retroillumination photographs were captured for group 1 eyes using the Topcon digital slit lamp, and these were analyzed using POCOman software to calculate an aggregate severity grade and percentage PCO value. Correlation coefficients were calculated for PCO values obtained using POCOman and ImageJ.</p>
<p><scp>results.</scp> Mean PCO percentage value obtained using POCOman software was 23.34 &plusmn; 6.25 U, mean aggregate PCO severity grade was 0.46 &plusmn; 0.28 U, and mean pixel-intensity value using ImageJ was 31.071 &plusmn; 8.26 U. There was a significant positive correlation between the percentage PCO (<I>P</I> = 0.000; <I>r</I> = 0.864) and PCO severity grade (<I>P</I> = 0.001; <I>r</I> = 0.490) obtained for group 1 eyes using slit lamp retroillumination images and PCO pixel intensity obtained using Pentacam tomograms.</p>
<p><scp>conclusions.</scp> Retroillumination photographs are the standard for quantifying PCO. Pentacam tomograms are easier to obtain and are free of flash reflections, and they allow for a more objective analysis. The correlation between the two methods demonstrates that ImageJ analysis of Pentacam tomograms is a viable tool for PCO analysis.</p>
]]></description>
<dc:creator><![CDATA[Grewal, D., Jain, R., Brar, G. S., Grewal, S. P. S.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1056</dc:identifier>
<dc:title><![CDATA[[Lens] Pentacam Tomograms: A Novel Method for Quantification of Posterior Capsule Opacification]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2008</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2004</prism:startingPage>
<prism:section>Lens</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2009?rss=1">
<title><![CDATA[[Lens] Effect of Superposed Electromagnetic Noise on DNA Damage of Lens Epithelial Cells Induced by Microwave Radiation]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2009?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To investigate the influence of the 1.8-GHz radiofrequency fields (RFs) of the Global System for Mobile Communications on DNA damage, intracellular reactive oxygen species (ROS) formation, cell cycle, and apoptosis in human lens epithelial cells (hLECs) and whether the effects induced by RF could be blocked by superposing of electromagnetic noise.</p>
<p><scp>methods.</scp> After 24-hour intermittent exposure at the specific absorption rate of 1 W/kg, 2 W/kg, 3 W/kg, and 4 W/kg, the DNA damage of hLECs was examined by alkaline comet assay and immunofluorescence microscope detection of the phosphorylated form of histone variant H2AX (H2AX) foci, respectively. ROS production was quantified by the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA). Cell cycle and cell apoptosis were determined by flow cytometry.</p>
<p><scp>results.</scp> DNA damage examined by alkaline comet assay was significantly increased after 3 W/kg and 4 W/kg radiation (<I>P</I> &lt; 0.05), whereas the double-strand breaks (DSBs) evaluated by H2AX foci were significantly increased only after 4 W/kg radiation (<I>P</I> &lt; 0.05). Significantly elevated intracellular ROS levels were also detected in the 3-W/kg and 4-W/kg groups (<I>P</I> &lt; 0.05). After exposure to 4 W/kg for 24 hours, hLECs exhibited significant G<SUB>0</SUB>/G<SUB>1</SUB> arrest (<I>P</I> &lt; 0.05). There was no detectable difference in cell apoptosis between the microwave radiation and sham exposure groups (<I>P</I> &gt; 0.05). All the effects mentioned were blocked when the RF was superposed with 2 &micro;T electromagnetic noise.</p>
<p><scp>conclusions.</scp> Microwave radiation induced hLEC DNA damage after G<SUB>0</SUB>/G<SUB>1</SUB> arrest does not lead to cell apoptosis. The increased ROS observed may be associated with DNA damage. Superposed electromagnetic noise blocks microwave radiation-induced DNA damage, ROS formation, and cell cycle arrest.</p>
]]></description>
<dc:creator><![CDATA[Yao, K., Wu, W., Yu, Y., Zeng, Q., He, J., Lu, D., Wang, K.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1333</dc:identifier>
<dc:title><![CDATA[[Lens] Effect of Superposed Electromagnetic Noise on DNA Damage of Lens Epithelial Cells Induced by Microwave Radiation]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2015</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2009</prism:startingPage>
<prism:section>Lens</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2016?rss=1">
<title><![CDATA[[Physiology and Pharmacology] Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2016?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Gene therapy offers a promising alternative for the treatment of ocular diseases. However, the implementation of this type of therapy is actually hampered by the lack of an efficient ocular gene delivery carrier. The main objective of the present work was to assess the effectiveness and investigate the mechanism of action of a new type of nanoparticle made of two bioadhesive polysaccharides, hyaluronic acid (HA) and chitosan (CS), intended for the delivery of genes to the cornea and conjunctiva.</p>
<p><scp>methods.</scp> The nanoparticles were obtained by a very mild ionotropic gelation technique. They were loaded with either the model plasmid pEGFP or p&beta;-gal. Transfection and toxicological studies were conducted in human corneal epithelial (HCE) and normal human conjunctival (IOBA-NHC) cell lines. The mechanism of internalization of the nanoparticles by the corneal and conjunctival cells was investigated by using fluorescence confocal microscopy.</p>
<p><scp>results.</scp> The nanoparticles had a size in the range of 100 to 235 nm and a -potential of &ndash;30 to +28 mV. The results of the transfection studies showed that HA-CS nanoparticles were able to provide high transfection levels (up to 15% of cells transfected), without affecting cell viability. The confocal images indicated that HA-CS nanoparticles were internalized by fluid endocytosis and that this endocytic process was mediated by the hyaluronan receptor CD44.</p>
<p><scp>conclusions.</scp> The results give evidence of the potential of HA-CS nanoparticles for the targeting and further transfer of genes to the ocular surface.</p>
]]></description>
<dc:creator><![CDATA[de la Fuente, M., Seijo, B., Alonso, M. J.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1077</dc:identifier>
<dc:title><![CDATA[[Physiology and Pharmacology] Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2024</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2016</prism:startingPage>
<prism:section>Physiology and Pharmacology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2025?rss=1">
<title><![CDATA[[Physiology and Pharmacology] Mapping of the Neonatal Fc Receptor in the Rodent Eye]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2025?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> The neonatal Fc receptor (FcRn) has been known to modulate IgG transport and protect against IgG catabolism, resulting in extension of the serum half-life of IgG. The goal of this study was to localize FcRn receptor expression in the rat&rsquo;s eye.</p>
<p><scp>methods.</scp> The cornea, retina, conjunctiva, ciliary body and iris, retinal pigment epithelium and choroid, and lens were dissected from each rat&rsquo;s eye, and total RNA was purified. The first-strand cDNAs were synthesized and subjected to PCR reaction. For control samples, reverse transcriptase was omitted. A monoclonal antibody against the FcRn heavy chain was used to localize the distribution of the FcRn receptor in ocular tissues. Lymphatic vessels and blood vessels were stained with a rabbit anti-mouse lymphatic vessel endothelial receptor-1 polyclonal antibody and a rabbit anti-human von Willebrand factor polyclonal antibody, respectively.</p>
<p><scp>results.</scp> RT-PCR demonstrated expression of FcRn RNA in cornea, retina, conjunctiva, ciliary body and iris, and lens but absence of expression in the retinal pigment epithelium and choroid. Immunohistochemistry and double staining confirmed the expression of FcRn receptor to the conjunctival lymphatic vessels but not in the conjunctival blood vessels. In the ciliary body, the FcRn receptor was found to be expressed in both the nonpigmented ciliary epithelium and the ciliary blood vessels. The expression of FcRn receptor was confirmed in the retinal blood vessels, iris blood vessels, optic nerve vascular structures, corneal epithelium and endothelium, and lens epithelium.</p>
<p><scp>conclusions.</scp> The FcRn receptor is expressed in multiple ocular tissues. The blood-ocular barrier showed FcRn receptor expression, indicating that IgG transport from ocular tissues to the blood system may use this receptor. The role of the FcRn receptor in the anterior segment and the conjunctiva remains unclear.</p>
]]></description>
<dc:creator><![CDATA[Kim, H., Fariss, R. N., Zhang, C., Robinson, S. B., Thill, M., Csaky, K. G.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0871</dc:identifier>
<dc:title><![CDATA[[Physiology and Pharmacology] Mapping of the Neonatal Fc Receptor in the Rodent Eye]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2029</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2025</prism:startingPage>
<prism:section>Physiology and Pharmacology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2030?rss=1">
<title><![CDATA[[Physiology and Pharmacology] Dexamethasone Inhibits High Glucose-, TNF-{alpha}-, and IL-1{beta}-Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2030?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To characterize the effects of dexamethasone in human retinal pericytes (HRMPs), monocytes (THP-1), and retinal endothelial cells (HRECs) treated with high glucose, TNF-, or IL-1&beta;.</p>
<p><scp>methods.</scp> HRMP and HREC phenotypes were verified by growth factor stimulation of intracellular calcium&ndash;ion mobilization. Glucocorticoid receptor phosphorylation was assessed with an anti-phospho-Ser<sup>211</sup> glucocorticoid receptor antibody. Secretion of 89 inflammatory and angiogenic proteins were compared in cells incubated with (1) normal (5 mM) or high (25 mM) <scp>d</scp>-glucose and (2) control medium, TNF- (10 ng/mL), or IL-1&beta; (10 ng/mL), with or without dexamethasone (1 nM to 1 &micro;M). The proteins were compared by using multianalyte profile testing.</p>
<p><scp>results.</scp> HRMPs and HRECs expressed functional PDGFB-R and VEGFR-2, respectively. Dexamethasone induction of glucocorticoid receptor phosphorylation was dose-dependent in all cell types. High glucose increased secretion of inflammatory mediators in HRMPs, but not in HRECs. Dexamethasone dose dependently inhibited secretion of these mediators in HRMPs. For all cells, TNF- and IL-1&beta; induced a fivefold or more increase in inflammatory and angiogenic mediators; HRMPs secreted the greatest number and level of mediators. Dexamethasone dose dependently inhibited the secretion of multiple proteins from HRMPs and THP-1 cells, but not from HRECs (IC<SUB>50</SUB> 2 nM to 1 &micro;M).</p>
<p><scp>conclusions.</scp> High glucose, TNF-, and IL-1&beta; induced an inflammatory phenotype in HRMPs, characterized by hypersecretion of inflammatory and angiogenic mediators. Dexamethasone at various potencies blocked hypersecretion of several proteins. Pericytes may be a key therapeutic target in retinal inflammatory diseases, including diabetic retinopathy. Inhibition of pathologic mediators may depend on delivering high levels (~1 &micro;M) of glucocorticoid to the retina.</p>
]]></description>
<dc:creator><![CDATA[Nehme, A., Edelman, J.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0273</dc:identifier>
<dc:title><![CDATA[[Physiology and Pharmacology] Dexamethasone Inhibits High Glucose-, TNF-{alpha}-, and IL-1{beta}-Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2038</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2030</prism:startingPage>
<prism:section>Physiology and Pharmacology</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2039?rss=1">
<title><![CDATA[[Retina] Thyroid Hormone Action Is Required for Normal Cone Opsin Expression during Mouse Retinal Development]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2039?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> The expression of S- and M-opsins in the murine retina is altered in different transgenic mouse models with mutations in the thyroid hormone receptor (TR)-&beta; gene, demonstrating an important role of thyroid hormone (TH) in retinal development.</p>
<p><scp>methods.</scp> The spatial expression of S- and M-opsin was compared in congenital hypothyroidism and in two different TR mutant mouse models. One mouse model contains a ligand-binding mutation that abolishes TH binding and results in constitutive binding to nuclear corepressors. The second model contains a mutation that blocks binding of coactivators to the AF-2 domain without affecting TH binding.</p>
<p><scp>results.</scp> Hypothyroid newborn mice showed an increase in S-opsin expression that was completely independent of the genotype. Concerning M-opsin expression, hypothyroidism caused a significant decrease (<I>P</I> &lt; 0.01) only in wild-type animals. When TR&beta;1 and -&beta;2 were T3-binding defective, the pattern of opsin expression was similar to TR&beta; ablation, showing increased S-opsin expression in the dorsal retina and no expression of M-opsin in the entire retina. In an unexpected finding, immunostaining for both opsins was detected when both subtypes of TR&beta; were mutated in the helix 12 AF-2 domain.</p>
<p><scp>conclusions.</scp> The results show, for the first time, that the expression of S- and M-opsin is dependent on normal thyroid hormone levels during development.</p>
]]></description>
<dc:creator><![CDATA[Pessoa, C. N., Santiago, L. A., Santiago, D. A., Machado, D. S., Rocha, F. A. F., Ventura, D. F., Hokoc, J. N., Pazos-Moura, C. C., Wondisford, F. E., Gardino, P. F., Ortiga-Carvalho, T. M.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0908</dc:identifier>
<dc:title><![CDATA[[Retina] Thyroid Hormone Action Is Required for Normal Cone Opsin Expression during Mouse Retinal Development]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2045</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2039</prism:startingPage>
<prism:section>Retina</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2046?rss=1">
<title><![CDATA[[Retina] Increased-Resolution OCT Thickness Mapping of the Human Macula: A Statistically Based Registration]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2046?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To describe the development of a technique that enhances spatial resolution of retinal thickness maps of the Stratus OCT (Carl Zeiss Meditec, Inc., Dublin, CA). A retinal thickness atlas (RT-atlas) template was calculated, and a macular coordinate system was established, to pursue this objective.</p>
<p><scp>methods.</scp> The RT-atlas was developed from principal component analysis of retinal thickness analyzer (RTA) maps acquired from healthy volunteers. The Stratus OCT radial thickness measurements were registered on the RT-atlas, from which an improved macular thickness map was calculated. Thereafter, Stratus OCT circular scans were registered on the previously calculated map to enhance spatial resolution.</p>
<p><scp>results.</scp> The developed technique was applied to Stratus OCT thickness data from healthy volunteers and from patients with diabetic retinopathy (DR) or age-related macular degeneration (AMD). Results showed that for normal, or close to normal, macular thickness maps from healthy volunteers and patients with DR, this technique can be an important aid in determining retinal thickness. Efforts are under way to improve the registration of retinal thickness data in patients with AMD.</p>
<p><scp>conclusions.</scp> The developed technique enhances the evaluation of data acquired by the Stratus OCT, helping the detection of early retinal thickness abnormalities. Moreover, a normative database of retinal thickness measurements gained from this technique, as referenced to the macular coordinate system, can be created without errors induced by missed fixation and eye tilt.</p>
]]></description>
<dc:creator><![CDATA[Bernardes, R., Santos, T., Cunha-Vaz, J.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-0467</dc:identifier>
<dc:title><![CDATA[[Retina] Increased-Resolution OCT Thickness Mapping of the Human Macula: A Statistically Based Registration]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2052</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2046</prism:startingPage>
<prism:section>Retina</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2053?rss=1">
<title><![CDATA[[Retina] C-Reactive Protein Inhibits Endothelium-Dependent Nitric Oxide-Mediated Dilation of Retinal Arterioles via Enhanced Superoxide Production]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2053?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> Elevated levels of C-reactive protein (CRP), a proinflammatory marker, are associated with systemic vascular disorders. In addition, clinical studies have implicated that elevated CRP is an independent risk factor for diabetic retinopathy and age-related macular degeneration. However, the direct effect of CRP on ocular microvascular reactivity remains unknown. The authors examined whether CRP can affect endothelium-dependent nitric oxide (NO)-mediated dilation of retinal arterioles and whether oxidative stress and distinct protein kinase signaling pathways are involved in the CRP-mediated effect.</p>
<p><scp>methods.</scp> Porcine retinal arterioles (internal diameter, 71 &plusmn; 2 &micro;m) were isolated and pressurized without flow for in vitro study. Diameter changes were recorded using videomicroscopic techniques. Dihydroethidium (DHE) was used to detect superoxide production.</p>
<p><scp>results.</scp> Intraluminal treatment with a clinically relevant concentration of CRP (7 &micro;g/mL, 60 minutes) significantly attenuated arteriolar dilation to endothelium-dependent NO-mediated agonists bradykinin and A23187 but not to endothelium-independent NO donor sodium nitroprusside. In the presence of superoxide scavenger TEMPOL, NAD(P)H oxidase inhibitor apocynin, p38 kinase inhibitor SB203580, simvastatin, or Rho-kinase inhibitor Y-27632, the detrimental effect of CRP on bradykinin-induced dilation was prevented. DHE staining showed that CRP produced TEMPOL-sensitive superoxide production in the arteriolar endothelium.</p>
<p><scp>conclusions.</scp> CRP inhibits endothelium-dependent NO-mediated dilation in retinal arterioles by producing superoxide from NAD(P)H oxidase, which appears to be linked with p38 kinase and RhoA/Rho-kinase activation. By impairing endothelium-dependent NO-mediated vasoreactivity, CRP can potentially facilitate the development of retinal vascular diseases. In addition, statins are beneficial by preserving endothelial function, possibly through inactivation of the RhoA/Rho-kinase pathway.</p>
]]></description>
<dc:creator><![CDATA[Nagaoka, T., Kuo, L., Ren, Y., Yoshida, A., Hein, T. W.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1387</dc:identifier>
<dc:title><![CDATA[[Retina] C-Reactive Protein Inhibits Endothelium-Dependent Nitric Oxide-Mediated Dilation of Retinal Arterioles via Enhanced Superoxide Production]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2060</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2053</prism:startingPage>
<prism:section>Retina</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2061?rss=1">
<title><![CDATA[[Retina] Foveal Fine Structure in Retinopathy of Prematurity: An Adaptive Optics Fourier Domain Optical Coherence Tomography Study]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2061?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To describe the fine structure of the fovea in subjects with a history of mild retinopathy of prematurity (ROP) using adaptive optics&ndash;Fourier domain optical coherence tomography (AO-FDOCT).</p>
<p><scp>methods.</scp> High-speed, high-resolution AO-FDOCT videos were recorded in subjects with a history of ROP (<I>n</I> = 5; age range, 14&ndash;26 years) and in control subjects (<I>n</I> = 5; age range, 18&ndash;25 years). Custom software was used to extract foveal pit depth and volume from three-dimensional (3-D) retinal maps. The thickness of retinal layers as a function of retinal eccentricity was measured manually. The retinal vasculature in the parafoveal region was assessed.</p>
<p><scp>results.</scp> The foveal pit was wider and shallower in ROP than in control subjects. Mean pit depth, defined from the base to the level at which the pit reaches a lateral radius of 728 &micro;m, was 121 &micro;m compared with 53 &micro;m. Intact, contiguous inner retinal layers overlay the fovea in ROP subjects but were absent in the control subjects. Mean full retinal thickness at the fovea was greater in the subjects with ROP (279.0 &micro;m vs. 190.2 &micro;m). The photoreceptor layer thickness did not differ between ROP and control subjects. An avascular zone was not identified in the subjects with ROP but was present in all the control subjects.</p>
<p><scp>conclusions.</scp> The foveas of subjects with a history of mild ROP have significant structural abnormalities that are probably a consequence of perturbations of neurovascular development.</p>
]]></description>
<dc:creator><![CDATA[Hammer, D. X., Iftimia, N. V., Ferguson, R. D., Bigelow, C. E., Ustun, T. E., Barnaby, A. M., Fulton, A. B.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1228</dc:identifier>
<dc:title><![CDATA[[Retina] Foveal Fine Structure in Retinopathy of Prematurity: An Adaptive Optics Fourier Domain Optical Coherence Tomography Study]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2070</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2061</prism:startingPage>
<prism:section>Retina</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2071?rss=1">
<title><![CDATA[[Retina] Association between Complement Factor H Gene Polymorphisms and Neovascular Age-Related Macular Degeneration in Koreans]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2071?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> This study was undertaken to investigate the association between the complement factor H (<I>CFH</I>) gene and exudative age-related macular degeneration (AMD) in Korean patients.</p>
<p><scp>methods.</scp> Genomic DNA was isolated from the peripheral leukocytes of patients with exudative AMD (<I>n</I> = 114) and control subjects (<I>n</I> = 187). The sole criterion for exudative AMD was the presence of choroidal neovascularization. Four single-nucleotide polymorphisms (SNPs: &ndash;275C&gt;T, I62V, Y402H, and IVS15) located in promoter, exon 2, exon 9, and intron 15 of the <I>CFH</I> gene were genotyped by PCR-based direct sequencing.</p>
<p><scp>results.</scp> The frequency of the C allele of Y402H (AMD, 10.5%; control, 6.5%) was found to be lower in Koreans than in Caucasians. In the present study, the difference between the frequencies of Y402H in cases and control subjects did not reach statistical significance (<I>P</I> = 0.071). However, the frequencies of the major alleles of three SNPs (&ndash;275C&gt;T, I62V, and IVS15) were significantly different in patients and control subjects, and these SNPs were found to be separately associated with an elevated risk of exudative AMD. Seven haplotypes were identified in Koreans. Haplotype analysis showed that two haplotypes (TGTG, CGTG) conferred significantly higher risks of exudative AMD (<I>P</I> = 0.013, 0.035), and one haplotype (CATA) was significantly protective (<I>P</I> &lt; 0.001).</p>
<p><scp>conclusions.</scp> In Korean subjects, <I>CFH</I> polymorphism appears to be a considerable hereditary contributor to exudative AMD. Y402H polymorphism which has been suggested to be a major risk factor of AMD in Caucasians was found to be only marginally associated with exudative AMD with low frequency, whereas three adjacent SNPs in the <I>CFH</I> gene were significantly associated with AMD in Koreans.</p>
]]></description>
<dc:creator><![CDATA[Kim, N. R., Kang, J. H., Kwon, O. W., Lee, S. J., Oh, J. H., Chin, H. S.]]></dc:creator>
<dc:date>2008-04-24</dc:date>
<dc:identifier>info:doi/10.1167/iovs.07-1195</dc:identifier>
<dc:title><![CDATA[[Retina] Association between Complement Factor H Gene Polymorphisms and Neovascular Age-Related Macular Degeneration in Koreans]]></dc:title>
<dc:publisher>Association</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>49</prism:volume>
<prism:endingPage>2076</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>2071</prism:startingPage>
<prism:section>Retina</prism:section>
</item>

<item rdf:about="http://www.iovs.org/cgi/content/full/49/5/2077?rss=1">
<title><![CDATA[[Retina] Foveal Cone-Photoreceptor Integrity in Aging Macula Disorder]]></title>
<link>http://www.iovs.org/cgi/content/full/49/5/2077?rss=1</link>
<description><![CDATA[
<p><scp>purpose.</scp> To establish the relation between AMD stage and a quantitative measure for the integrity of foveal cone photoreceptors related to the optical Stiles-Crawford effect.</p>
<p><scp>methods.</scp> Fifty-six AMD eyes and 57 control eyes were included in the final analysis. AMD was graded in accordance with the International Classification System into five mutually exclusive stages. Stages 0 to 1 were labeled no AMD, stages 2 to 3 were labeled early AMD, and stage 4 was labeled late AMD. Fundus reflectometry, together with a model-fit procedure, provided information on directional cone reflectance (Rd), a quantitative measure for the integrity of foveal cone photoreceptors. Optical densities of macular pigment (MPOD) and melanin (MOD) were also obtained. A general linear model analysis was used to compare Rd, MPOD, and MOD among the AMD stages.</p>
<p><scp>results.</scp> Mean Rd was lower in early AMD (0.92%, <I>P</I> &lt; 0.001) and late AMD (0.86%, <I>P</I> &lt; 0.001) compared with mean Rd in the no-AMD stage (1.76%). Mean MPOD was not different in early AMD (0.53, <I>P</I> = 0.05), but it was lower in late AMD (0.19, <I>P</I> &lt; 0.001) compared with mean MPOD in the no-AMD stage (0.42). Mean MOD was lower in early (1.09, <I>P</I> = 0.001) and late (1.01, <I>P</I> = 0.004) AMD compared with mean MOD in the no-AMD stage (1.23).</p>
<p><scp>conclusions.</scp> Foveal cones show signs of misalignment and/or outer segment deterioration in early AMD. Melanin rather than macular pigment may play a protective role against AMD, although loss of these ocular pigments can also be caused by AMD.</p>
]]></description>
<dc:creator><![CDATA[Kanis, M. J., Wisse, R. P. L., Berendschot, T. T. J. M., van de Kraats,